| View |
DR-XY40112_PI_01.pdf
|
DR-XY40112
|
Olmesartan medoxomil + Amlodipine (as besilate) + Hydrochlorothiazide
|
Tri-Alzor
|
40mg/5mg/ 12.5mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker Combination
|
Ajanta Pharma Limited
|
India
|
Renewal
|
20 August 2024
|
30 September 2029
|
| View |
DR-XY40113_PI_01.pdf
|
DR-XY40113
|
Olmesartan medoxomil + Amlodipine (as besilate) + Hydrochlorothiazide
|
Tri-Alzor
|
40mg/10mg/ 12.5mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker Combination
|
Ajanta Pharma Limited
|
India
|
Renewal
|
04 August 2024
|
30 September 2029
|
| View |
DR-XY40120_PI_01.pdf
|
DR-XY40120
|
Atorvastatin (as calcium propylene glycol solvate)
|
Atorvast-Natrapharm
|
40mg
|
Film-Coated Tablet
|
Antihyperlipidemic (HMG CoA reductase inhibitor)
|
Apotex Inc.
|
Canada
|
Renewal
|
07 April 2024
|
04 October 2029
|
| View |
|
DR-XY40127
|
Nalbuphine (as Hydrochloride)
|
Analin
|
20mg/ mL
|
Solution for Injection
|
OPIOID/ANALGESIC
|
Medicaids Pakistan (Private) Limited
|
Pakistan
|
Automatic Renewal
|
19 August 2021
|
05 October 2026
|
| View |
|
DR-XY40129
|
METOCLOPRAMIDE (as Hydrochloride)
|
GASTROSIL
|
5mg/5mL
|
Syrup
|
Gastrokinetic (Prokinetic)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
01 April 2022
|
28 October 2026
|
| View |
|
DR-XY40130
|
Diphenhydramine Hydrochloride
|
Bexil
|
50mg/ mL
|
Solution for Injection (IM/IV)
|
Antihistamine/Anti-pruritic
|
Zhejiang Ruixin Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
21 September 2021
|
07 October 2026
|
| View |
|
DR-XY40131
|
Clonidine (as hydrochloride)
|
Terclodine
|
150 mcg
|
TABLET
|
Alpha-2 Adrenoceptor Agonist
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
20 July 2023
|
07 October 2028
|
| View |
|
DR-XY40132
|
Lidocaine Hydrochloride (as monohydrate)
|
EUROCAINE
|
20mg/ mL (2% w/v)
|
Solution for Injection
|
Local Anesthetic/Antiarrhythmic
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
20 July 2021
|
05 October 2026
|
| View |
|
DR-XY40137
|
0.9% Sodium Chloride
|
None
|
900 mg/100 mL
|
Solution For IV Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
29 July 2020
|
23 September 2025
|
| View |
|
DR-XY40146
|
Esomeprazole
|
Esofag
|
20mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
21 September 2021
|
12 October 2026
|
| View |
|
DR-XY40158
|
Ceftazidime (As Pentahydrate)
|
None
|
1g
|
Powder For Injection (IM/IV)
|
-
|
Sinopharm Zhijun (Shenzhen) Pharmaceutical Co.,
|
China
|
-
|
20 November 2020
|
11 October 2025
|
| View |
|
DR-XY40171
|
Pioglitazone (As Hydrochloride) + Glimepiride
|
Zoliget
|
15mg/2mg
|
Tablet
|
Blood Glucose-Lowering Drug
|
Getz Pharma (Private Limited
|
Pakistan
|
Automatic Renewal
|
17 July 2021
|
14 October 2026
|
| View |
|
DR-XY40175
|
Paclitaxel
|
Paclib
|
6 mg/ mL
|
Concentrate Solution (IV)
|
-
|
Laboratorios Richmond S.A.C.I.F.
|
Argentina
|
-
|
14 April 2021
|
14 October 2026
|
| View |
|
DR-XY40178
|
GLIBENCLAMIDE
|
None
|
5mg
|
Tablet
|
Oral Hypoglycemic
|
Lloyd Laboratories, Inc
|
Philippines
|
Automatic Renewal
|
14 September 2021
|
14 October 2026
|
| View |
|
DR-XY40179
|
Ketotifen (as Fumarate)
|
Ketotif
|
1mg/5mL
|
Syrup
|
Antihistamine
|
Delta Pharma Limited
|
Bangladesh
|
Renewal
|
07 August 2024
|
14 October 2029
|
| View |
|
DR-XY40185
|
Paracetamol/ Ibuprofen 325 Mg/ 200 Mg Capsule
|
None
|
325 mg/200 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug/ Analgesic/ Antipyretic
|
Northfield Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
21 September 2021
|
13 October 2026
|
| View |
|
DR-XY40186
|
Phenylephrine Hydrochloride + Chlorpheniramine Maelate
|
Coldeze Infant Drops
|
1mg/ 800mcg permL
|
Syrup (Oral Drops)
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 September 2021
|
13 October 2026
|
| View |
|
DR-XY40190
|
AMINO ACIDS CRYSTALLINE
|
Aminoplasmal B. Braun 10% E
|
0.1
|
Solution for Infusion (I.V.)
|
Parenteral
|
B. BRAUN MELSUNGEN AG
|
Germany
|
Automatic Renewal
|
22 January 2022
|
14 October 2026
|
| View |
|
DR-XY40196
|
Levamlodipine (as Besilate)
|
Esem
|
5 mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
MSN Laboratories Private Limited
|
India
|
Renewal
|
27 October 2024
|
17 October 2029
|
| View |
|
DR-XY40197
|
Levamlodipine (as Besilate)
|
Esem
|
2.5 mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
MSN Laboratories Private Limited
|
India
|
Renewal
|
21 October 2024
|
17 October 2029
|